Federal Register Recent Federal Regulation Documents - Justia Regulation Tracker - Justia Regulations Trackerhttps://regulations.justia.com/regulations/fedreg/agencies/department-of-health-and-human-services/2022/12/08?limit=200®isters=between&mode=atom2024-05-18T09:50:28-07:00Justia Inchttps://www.justia.com/Justia Regulations Trackerhttps://regulations.justia.com/images/justiafedregulations.gifCopyright 2011 Justia Inchttps://regulations.justia.com/regulations/fedreg/2022/12/08/2022-26711.htmlNotice - Recommendations To Reduce the Risk of Transfusion-Transmitted Malaria; Guidance for Industry; Availability2022-12-08T00:00:00-08:002022-12-08T00:00:00-08:002022-26711Noticehttps://www.govinfo.gov/content/pkg/FR-2022-12-08/pdf/2022-26711.pdfhttps://regulations.justia.com/regulations/fedreg/2022/12/08/2022-26717.htmlNotice - Center for Scientific Review; Notice of Closed Meeting2022-12-08T00:00:00-08:002022-12-08T00:00:00-08:002022-26717Noticehttps://www.govinfo.gov/content/pkg/FR-2022-12-08/pdf/2022-26717.pdfhttps://regulations.justia.com/regulations/fedreg/2022/12/08/2022-26695.htmlNotice - National Vaccine Injury Compensation Program; List of Petitions Received2022-12-08T00:00:00-08:002022-12-08T00:00:00-08:002022-26695Noticehttps://www.govinfo.gov/content/pkg/FR-2022-12-08/pdf/2022-26695.pdfhttps://regulations.justia.com/regulations/fedreg/2022/12/08/2022-26664.htmlNotice - Availability of Final Guidelines for Examining Unusual Patterns of Cancer and Environmental Concerns2022-12-08T00:00:00-08:002022-12-08T00:00:00-08:002022-26664Noticehttps://www.govinfo.gov/content/pkg/FR-2022-12-08/pdf/2022-26664.pdfhttps://regulations.justia.com/regulations/fedreg/2022/12/08/2022-26663.htmlNotice - Determination That NORFLEX (Orphenadrine Citrate) Injection, 30 Milligrams/Milliliter, and NORFLEX (Orphenadrine Citrate) Extended-Release Tablet, 100 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness2022-12-08T00:00:00-08:002022-12-08T00:00:00-08:002022-26663Noticehttps://www.govinfo.gov/content/pkg/FR-2022-12-08/pdf/2022-26663.pdfhttps://regulations.justia.com/regulations/fedreg/2022/12/08/2022-26661.htmlNotice - Teva Branded Pharmaceutical Products R and D, Inc., et al.; Withdrawal of Approval of 35 New Drug Applications2022-12-08T00:00:00-08:002022-12-08T00:00:00-08:002022-26661Noticehttps://www.govinfo.gov/content/pkg/FR-2022-12-08/pdf/2022-26661.pdf